Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

Kieren D. Marini, David R. Croucher, Rachael A. McCloy, Vijesh Vaghjiani, Alvaro Gonzalez-Rajal, Jordan F. Hastings, Venessa Chin, Anette Szczepny, Kaja Kostyrko, Cesar Marquez, W. Samantha, N. Jayasekara, Muhammad Alamgeer, Vishal Boolell, Jeremy Z.R. Han, Todd Waugh, Hong Ching Lee, Samantha R. Oakes, Beena Kumar, Craig A. HarrisonMark P. Hedger, Nirmal Lorensuhewa, Badia Kita, Ross Barrow, Bruce W. Robinson, David M. De Kretser, Jianmin Wu, Vinod Ganju, E. Alejandro Sweet-Cordero, Andrew Burgess, Luciano G. Martelotto, Fernando J. Rossello, Jason E. Cain, D. Neil Watkins

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science